BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Trastuzumab|DRUG: Carboplatin|DRUG: Bevacizumab|DRUG: 5-Fluorouracil|DRUG: Epirubicin|DRUG: Cyclophosphamide
Sponsor: NSABP Foundation Inc
Collaborators: Cancer International Research Group (CIRG)|Hoffmann-La Roche|Genentech, Inc.